BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Estevinho MM, Afonso J, Rosa I, Lago P, Trindade E, Correia L, Dias CC, Magro F; GEDII [Portuguese IBD Group]. Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis. J Crohns Colitis 2018;12:1232-44. [PMID: 30010736 DOI: 10.1093/ecco-jcc/jjy100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Estevinho MM, Magro F. The Impact of SARS-CoV-2 on Inflammatory Bowel Disease. GE Port J Gastroenterol 2020;27:227-9. [PMID: 32775543 DOI: 10.1159/000508114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu G, Xing G, Zhang B, Zhu J, Cai Y, Shen T, Rao J, Shi R, Cao Z, Nguyen T. The Relieving Effects of a Polyherb-Based Dietary Supplement ColonVita on Gastrointestinal Quality of Life Index (GIQLI) in Older Adults with Chronic Gastrointestinal Symptoms Are Influenced by Age and Cardiovascular Disease: A 12-Week Randomized Placebo-Controlled Trial. Evid Based Complement Alternat Med 2021;2021:6653550. [PMID: 34539805 DOI: 10.1155/2021/6653550] [Reference Citation Analysis]
3 Enck P, Klosterhalfen S. The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:641436. [PMID: 33867990 DOI: 10.3389/fphar.2021.641436] [Reference Citation Analysis]
4 Enck P, Klosterhalfen S. Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders. Front Psychiatry 2020;11:797. [PMID: 33192627 DOI: 10.3389/fpsyt.2020.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Harji D, Fernandez B, Boissieras L, Berger A, Capdepont M, Zerbib F, Rullier E, Denost Q. A novel bowel rehabilitation programme after total mesorectal excision for rectal cancer: the BOREAL pilot study. Colorectal Dis 2021. [PMID: 34264005 DOI: 10.1111/codi.15812] [Reference Citation Analysis]
6 Yarlas A, Maher S, Bayliss M, Lovley A, Cappelleri JC, Bushmakin AG, DiBonaventura MD. The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis. J Patient Cent Res Rev 2020;7:189-205. [PMID: 32377552 DOI: 10.17294/2330-0698.1722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shirazi M, Jalalian MN, Abed M, Ghaemi M. The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial. Rev Bras Ginecol Obstet 2021;43:126-30. [PMID: 33465795 DOI: 10.1055/s-0040-1721857] [Reference Citation Analysis]
8 Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, Broer M, Watts C, Tompson DJ, Burriss SW, Hawkins S, Abbott-Banner K, Tak PP. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol 2021;8:e000680. [PMID: 34389633 DOI: 10.1136/bmjgast-2021-000680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ling F, Tu L, Li J, Chen Y, Xu M, Zhu L. Psychological aspect of patients with inflammatory bowel disease, which may be related to the quality of life, sleep and disease characteristics. Scand J Gastroenterol 2021;56:1328-36. [PMID: 34448648 DOI: 10.1080/00365521.2021.1966093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Magro F, Estevinho MM, Dias CC, Correia L, Lago P, Ministro P, Portela F, Feakins R, Danese S, Peyrin-Biroulet L. Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis. J Crohns Colitis 2021;15:551-66. [PMID: 32898223 DOI: 10.1093/ecco-jcc/jjaa176] [Reference Citation Analysis]
11 Ge X, Jiang L, Yu W, Wu Y, Liu W, Qi W, Cao Q, Bai R, Zhou W. The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients. Dig Liver Dis 2021;53:965-71. [PMID: 33934998 DOI: 10.1016/j.dld.2021.03.031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Siafis S, Çıray O, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis. Mol Autism 2020;11:66. [PMID: 32847616 DOI: 10.1186/s13229-020-00372-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]